NASDAQ:EUDA EUDA Health (EUDA) Stock Price, News & Analysis $15.88 -0.33 (-2.01%) Closing price 03:57 PM EasternExtended Trading$15.62 -0.25 (-1.57%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC Filings About EUDA Health Stock (NASDAQ:EUDA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get EUDA Health alerts:Sign Up Key Stats Today's Range$15.90▼$16.4750-Day Range$13.10▼$20.3552-Week Range$5.26▼$86.00Volume5,437 shsAverage Volume51,523 shsMarket Capitalization$47.47 millionP/E RatioN/ADividend YieldN/APrice Target$55.00Consensus RatingHold Company Overview EUDA Health Holdings Limited is a digital health company focused on using technology to improve access to healthcare services. The company operates through subsidiaries and develops digital platforms intended to connect patients with healthcare providers and support the delivery of healthcare services. Its activities include telemedicine and other technology-enabled healthcare solutions, such as facilitating virtual consultations, healthcare appointments and related services. EUDA has also pursued artificial-intelligence applications in sexual health, including technology designed to support the assessment of certain male sexual-health conditions. The company is based in Singapore and has focused its operations on the Southeast Asian healthcare market. EUDA Health Holdings became a publicly traded company on the Nasdaq following a business combination with a special purpose acquisition company. Information about its current leadership and the full scope of its operating subsidiaries is limited.AI Generated. May Contain Errors. Read More EUDA Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks72nd Percentile Overall ScoreEUDA MarketRank™: EUDA Health scored higher than 72% of companies evaluated by MarketBeat, and ranked 77th out of 185 stocks in the real estate sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingEUDA Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialEUDA Health has a consensus price target of $55.00, representing about 248.7% upside from its current price of $15.77.Amount of Analyst CoverageEUDA Health has only been the subject of 1 research reports in the past 90 days.Read more about EUDA Health's stock forecast and price target. Earnings and ValuationN/AProj. Earnings GrowthN/A Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.05% of the float of EUDA Health has been sold short.Short Interest Ratio / Days to CoverEUDA Health has a short interest ratio ("days to cover") of 0.04, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in EUDA Health has recently decreased by 37.95%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEUDA Health does not currently pay a dividend.Dividend GrowthEUDA Health does not have a long track record of dividend growth. News and Social Media2.5 / 5News Sentiment0.93 News SentimentEUDA Health has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Real Estate companies.News Coverage This WeekMarketBeat has tracked 2 news articles for EUDA Health this week, compared to 3 articles on an average week. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, EUDA Health insiders have not sold or bought any company stock.Percentage Held by Institutions4.35% of the stock of EUDA Health is held by institutions.Read more about EUDA Health's insider trading history. Receive EUDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EUDA Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EUDA Stock News HeadlinesEUDA Health Holdings Limited Subsidiary Melana International Recognized as SME100 Awards 2026 Singapore WinnerAugust 26, 2026 | quiverquant.comQEUDA Health Subsidiary Melana International Wins SME100 Awards 2026 SingaporeAugust 26, 2026 | globenewswire.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.September 29 at 1:00 AM | Chaikin Analytics (Ad)EUDA Health Holdings Ltd. WtAugust 5, 2026 | barrons.comEUDA Health, GO POSB, Shenzhen Innovation Plan Cell Therapy CollaborationJuly 30, 2026 | finance.yahoo.comEUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology productsJuly 30, 2026 | globenewswire.comEUDA Health Signs Tri-Party MOU to Develop Next-Generation Oncology Cell TherapiesJuly 28, 2026 | tipranks.comEUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell TherapiesJuly 28, 2026 | globenewswire.comSee More Headlines EUDA Stock Analysis - Frequently Asked Questions How have EUDA shares performed this year? EUDA Health's stock was trading at $46.20 at the start of the year. Since then, EUDA shares have decreased by 65.9% and is now trading at $15.7710. How were EUDA Health's earnings last quarter? EUDA Health Holdings Limited (NASDAQ:EUDA) released its quarterly earnings results on Tuesday, May, 5th. The company reported ($0.44) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.20) by $0.76. The business earned $1.92 million during the quarter, compared to the consensus estimate of $3.90 million. When did EUDA Health's stock split? EUDA Health shares reverse split on the morning of Monday, March 23rd 2026.A 1-20 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, March 22nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. How do I buy shares of EUDA Health? Shares of EUDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of EUDA Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that EUDA Health investors own include Aptorum Group (APM), Avalo Therapeutics (AVTX), Coya Therapeutics (COYA), Deswell Industries (DSWL), Dawson Geophysical (DWSN), GT Biopharma (GTBP) and Company Calendar Last Earnings5/05/2026Today9/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 EUDA's financial health is in the Green zone, according to TradeSmith. EUDA has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorReal Estate Industry Real Estate Management & Development Sub-IndustryReal Estate Services Current SymbolNASDAQ:EUDA Previous SymbolNASDAQ:LAX CIK1847846 Webwww.eudahealth.com Phone65-6788-0388Fax65-6788-0068Employees2Year Founded2022Price Target and Rating Average Price Target for EUDA Health$55.00 High Price Target$55.00 Low Price Target$55.00 Potential Upside/Downside+246.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.18 Quick Ratio0.18 Sales & Book Value Annual Sales$6.82 million Price / Sales6.96 Cash FlowN/A Price / Cash FlowN/A Book Value($2.26) per share Price / Book-7.03Miscellaneous Outstanding Shares2,990,000Free FloatN/AMarket Cap$47.49 million OptionableNot Optionable Beta0.59 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:EUDA) was last updated on 9/29/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EUDA Health Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share EUDA Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
